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Conﬁrmatory test of two factors and four subtypes
of bipolar disorder based on lifetime psychiatric
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Background. The ﬁrst aim was to use conﬁrmatory factor analysis (CFA) to test a hypothesis that two factors (internalizing and externalizing) account for lifetime co-morbid DSM-IV diagnoses among adults with bipolar I (BPI) disorder.
The second aim was to use conﬁrmatory latent class analysis (CLCA) to test the hypothesis that four clinical subtypes are
detectible: pure BPI; BPI plus internalizing disorders only; BPI plus externalizing disorders only; and BPI plus internalizing and externalizing disorders.
Method. A cohort of 699 multiplex BPI families was studied, ascertained and assessed (1998–2003) by the National
Institute of Mental Health Genetics Initiative Bipolar Consortium: 1156 with BPI disorder (504 adult probands; 594
ﬁrst-degree relatives; and 58 more distant relatives) and 563 ﬁrst-degree relatives without BPI. Best-estimate consensus
DSM-IV diagnoses were based on structured interviews, family history and medical records. MPLUS software was used
for CFA and CLCA.
Results. The two-factor CFA model ﬁt the data very well, and could not be improved by adding or removing paths. The
four-class CLCA model ﬁt better than exploratory LCA models or post-hoc-modiﬁed CLCA models. The two factors and
four classes were associated with distinctive clinical course and severity variables, adjusted for proband gender. Comorbidity, especially more than one internalizing and/or externalizing disorder, was associated with a more severe
and complicated course of illness. The four classes demonstrated signiﬁcant familial aggregation, adjusted for gender
and age of relatives.
Conclusions. The BPI two-factor and four-cluster hypotheses demonstrated substantial conﬁrmatory support. These
models may be useful for subtyping BPI disorders, predicting course of illness and reﬁning the phenotype in genetic
studies.
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Introduction
Bipolar (BP) affective disorder affects 0.5–1.6% of the
US adult population and is frequently chronically
debilitating (Goodwin & Jamison, 1990; World
Health Organization, 2002). BP type I (BPI) illness is
highly heritable with up to 80% of risk determined
by genetic factors (Gershon et al. 1987; Tsuang &
Faraone, 1990; Nurnberger & Berrettini, 1998; Potash
& DePaulo, 2000; McMahon et al. 2001; Smoller &
Finn, 2003). The characterization of BPI subtypes of
persons may be helpful for early detection and for
understanding course of illness, neurobiology and
treatment response. Subtypes may be characterized
by clinical variables, including patterns of co-morbid
psychiatric symptoms and disorders (Nurnberger,
2002; Cassidy et al. 2008; Cassano et al. 2009). The creation of homogeneous BPI subgroups based on
co-morbid conditions has modestly improved the success of genetic mapping (MacKinnon et al. 1998;
Nurnberger, 2002; Schulze & McMahon, 2003;
MacQueen et al. 2005; Payne et al. 2005; Cheng et al.
2006; Saunders et al. 2009). For example, three subtypes
of BPI, as deﬁned by co-morbidity, have provided
some of the strongest evidence of linkage to genomic
regions: co-morbid panic disorder, co-morbid psychotic symptoms, and pure BPI with low rates of
co-morbidity (MacQueen et al. 2005). A subtype of
BPI characterized by co-morbid anxiety disorders has
been supported by cross-sectional, longitudinal and
familial studies (Johnson et al. 2000; Schurhoff et al.
2000; Birmaher et al. 2002; Goodwin & Hamilton,
2002; MacKinnon et al. 2002; Wozniak et al. 2002). A
BPI subtype characterized by high rates of co-morbid
drug and alcohol abuse or dependence (Sonne &
Brady, 1999; Nurnberger et al. 2007) has shown evidence for elevated genetic predisposition to substance
use disorders (Winokur et al. 1970, 1995, 1996; Helzer
& Winokur, 1974; Morrison, 1974, 1975; Gershon
et al. 1982; Kendler et al. 1993; Feinman & Dunner,
1996; Maier & Merikangas, 1996; Duffy et al. 1998;
DelBello et al. 1999; Strakowski & DelBello, 2000;
Nurnberger et al. 2007). Finally, offspring of BPI
patients (compared with controls) have higher rates
of affective, anxiety and externalizing disorders such
as conduct disorder, oppositional disorder and substance abuse (Gershon et al. 1985; Nurnberger et al.
1988, 2011; Todd et al. 1996; Lapalme et al. 1997;
Chang et al. 2000, 2003; DelBello & Geller, 2001).
Factor analysis and cluster analysis are complementary methods for investigating BPI clinical subtypes.
They determine, respectively, whether co-morbid variables (e.g. symptoms or lifetime disorders) can be parsimoniously explained by a fewer number of factors
(i.e. clusters of variables) and whether BPI persons

can be subdivided into subgroups (i.e. clusters of persons) (see online Supplementary Text, Section B).
Factor analyses have been conducted on psychiatric
lifetime disorders among community samples. For
example, an internalizing factor and an externalizing
factor were found (Kessler et al. 2011). However, no
published study has used a factor analysis, cluster
analysis or a latent cluster analysis (called latent class
analysis; LCA) to explore or test hypotheses about
the lifetime disorders co-morbid with BPI.
The ﬁrst purpose of this paper was to disseminate the
ﬁrst published investigation of lifetime disorders (i.e. instead of symptoms) in a conﬁrmatory test of a hypothesized factor analysis model among BPI individuals.
Based on literature cited above, we hypothesized a twofactor lifetime co-morbidity model, speciﬁed before
conﬁrmatory factor analysis (CFA) was performed and
then tested with CFA; in which internalizing and externalizing factors are correlated; and for which the internalizing factor explains correlations between anxiety,
somatoform and eating disorders; and the externalizing
factor explains correlations between alcohol use, drug
use, cluster B personality, impulse control, attentiondeﬁcit and disruptive disorders.
No published study has tested hypotheses about
clinical subtypes, among BPI patients, by using a conﬁrmatory approach to LCA, neither with symptoms nor
disorders. Conﬁrmatory LCA (CLCA) provides a
powerful method to test and validate hypotheses
about subgroups of persons with BPI (Finch &
Bronk, 2011).
Thus, the second, and primary, purpose of this
paper was to provide a conﬁrmatory test of a hypothesis about subgroups of BPI lifetime co-morbid disorders, speciﬁed before CLCA was performed and then
tested with CLCA. Based on literature cited above,
we hypothesized four co-morbidity subtypes of BPI
patients: pure BPI without co-morbidity; co-morbidity
with only internalizing disorders; co-morbidity with
only externalizing disorders; and co-morbidity with
both internalizing and externalizing disorders.
Method
Study design and procedures
The National Institute of Mental Health (NIMH)
Genetics Initiative Bipolar Project was active from
1989 to 2007. This article uses data from probands
and relatives assessed between 1998 and 2003 using
the Diagnostic Interview for Genetic Studies (DIGS)
3.0 interview and resulting Diagnostic and Statistical
Manual of Mental Disorders, 4th edition (DSM-IV)
diagnoses. At each of 10 sites, multiplex families
were ascertained through a proband and a ﬁrst-degree

Conﬁrmatory test of two factors and four subtypes of bipolar disorder
relative, both with a DSM-IV diagnosis of BPI or
schizo-affective BP type (for the diagnostic process,
see online Supplementary Text, Section A). Diagnoses
were coded as binary (0 = no, 1 = yes if ‘probable’ or
‘deﬁnite’).
Statistical methods
MPLUS software (version 5.21) (Muthén & Muthén,
1998–2007) was used to perform CFA and CLCA on
1156 individuals (504 probands and 652 relatives)
with BPI disorder using the COMPLEX option to account for the relatedness of individuals within families.
Criteria of good overall CFA model ﬁt were the following: comparative ﬁt index (CFI) > 0.95 (Hu & Bentler,
1999), root mean square error of approximation
(RMSEA) < 0.06 (Hu & Bentler, 1999), and weighted
root mean square residual (WRMR) < 1.00 (Yu, 2002).
Loadings above 0.40 indicated adequate ﬁt for individual paths (Nunnally & Bernstein, 1994). We tested
(two-sided, 0.05 α) whether ﬁt of the CFA model
could be improved by adding or removing paths (see
online Supplementary Text, Section C). The robust
weighted least squares (WLSMV) estimator and the
non-linear probit link were speciﬁed for CFA models.
For LCA and CLCA models, maximum likelihood
with robust standard error estimation was used.
An important deterministic constraint in CLCA
models is the hypothesized ‘zero’ class for which the
probabilities of endorsing all co-morbid disorders are
ﬁxed to be zero (e.g. ‘pure BP’ class) (Muthén &
Asparouhov, 2006). Our BPI subtyping hypothesis
required two other deterministic constraints: an ‘externalizing only’ class for which the probabilities of endorsing the externalizing disorders were freely
estimated and the probabilities of endorsing the internalizing disorders were ﬁxed to zero, and an ‘internalizing only’ class for which the probabilities of
endorsing the internalizing disorders were freely estimated and the probabilities of endorsing the externalizing disorders were ﬁxed to zero. To ﬁx a probability to
zero, the threshold of the disorder was constrained to
equal 15, which ﬁxes the probability of disorder endorsement to a value extremely close to zero (Finch
& Bronk, 2011; Clark et al. 2013). We hypothesized a
‘both class’ of BP persons who have substantial probability of both internalizing and externalizing lifetime
disorders for which probabilities were freely estimated
for all internalizing and externalizing disorders.
Additionally, we used equality and inequality constraints to test two competing versions of the hypothesized four-class CLCA model, which we speciﬁed a
priori before analyses. In the ‘equality’ model we
used equality constraints to test the hypothesis that
the probabilities of the externalizing disorders were
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not statistically different for the ‘both’ class and the
‘externalizing-only’ class, and the probabilities of the
internalizing disorders were not statistically different
for the ‘both’ class and the ‘internalizing-only’ class.
In the ‘inequality’ model, we hypothesized that the
probabilities of the externalizing disorders were
statistically greater for the ‘both’ class than the
‘externalizing-only’ class, and the probabilities of the
internalizing disorders were statistically greater for
the ‘both’ class than the ‘internalizing class’. Further
discussion of the equality and inequality hypotheses
is contained in Section B of online Supplementary
Text. These two competing four-class CLCA models
amount to specifying a priori a small speciﬁc slice of
the universe of possible equality and inequality constraints, deterministic constraints and number of
classes.
The ﬁt of CLCA and LCA models was evaluated
based on the following criteria. Models with the lowest
values for the Bayesian information criterion (BIC),
and its sample size-adjusted version (aBIC), were considered the best (Lubke & Muthén, 2005). The BIC and
aBIC were used to compare different models with different number of classes and or parameterizations
(Finch & Bronk, 2011). The likelihood ratio test (LRT)
was used to compare the hypothesized four-class
CLCA models with the exploratory four-class model,
because the former is nested within the latter (Finch
& Bronk, 2011). The LRT is not appropriate for comparing LCA models with differing number of classes
(Lubke & Muthén, 2005). Therefore, the Lo–Mendell–
Rubin (LMR) (Lo et al. 2001) LRT was used to compare
nested LCA models that have differing numbers of
classes but the same parameterization (e.g. our exploratory one-, two-, three-, four-, ﬁve- and six-class
LCA models). The LMR p value indicates whether a
model with one fewer classes can be rejected in favor
of the current model. Classes with a sparse number
of persons are not practically meaningful (Lubke &
Muthén, 2005). Therefore, we rejected models that included classes with a sample size representing less
than 5% of the sample. Post-hoc modiﬁcations to the
CLCA models were considered by inspecting graphs
of the ‘proﬁle’ of estimated disorder probabilities for
each of the four classes.
Only the disorders that were diagnosed in at least 50
BPI participants were included as individual variables
in the CFA and CLCA models to ensure estimation
precision. Some clinically similar disorders (e.g. panic
disorder with and without agoraphobia) were combined because, if not combined, diagnostic mutual exclusion would have prevented them from loading on
the same factor. The combined variables were coded
‘1’ if any of the contributing diagnoses were ‘1’ (probable or deﬁnite), and 0 otherwise.
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Table 1. Conﬁrmatory factor analysis of co-morbid lifetime disorders from 1156 BPI probands and BPI relatives
Variables

1
2
3
4

5
6
7

Factors
Factor 1: internalizing factor
Panic, agoraphobia, anxiety NOS, GAD, PTSD
Any phobia disorder (speciﬁc or social)
OCD
Any eating (anorexia, bulimia, NOS)
or somatoform disorder
Factor 2: externalizing factor
Any alcohol abuse or dependence
Any drug abuse or dependence
Cluster B personality disorder, impulse control,
conduct disorder, ADHD
Correlation between factor 1 and factor 2

Numbera

Loading (S.E.)

315
164
79
89

0.81 (0.08)
0.50 (0.06)
0.55 (0.08)
0.55 (0.07)

9.86
9.35
7.27
7.50

<0.001
<0.001
<0.001
<0.001

444
329
87

0.86 (0.07)
0.79 (0.06)
0.50 (0.07)

13.30
14.11
7.70

<0.001
<0.001
<0.001

5.31

<0.001

0.34 (0.06)

z

p

Model ﬁt
CFI
1.000

Fit indices
RMSEA
0.000

WRMR
0.556

χ2 Test
χ2 (df)
p
9.29 (11)
0.60

BPI, Bipolar I; S.E., standard error; z, loading/standard error; NOS, not otherwise speciﬁed; GAD, generalized anxiety disorder; PTSD, post-traumatic stress disorder; OCD, obsessive compulsive disorder; ADHD, attention-deﬁcit/hyperactivity disorder; CFI, comparative ﬁt index; RMSEA, root mean square error of approximation; WRMR, weighted root mean square
residual; df, degrees of freedom.
a
Number of 1156 persons with presence (probable or deﬁnite) for each variable; each variable is deﬁned as either an individual disorder (e.g. OCD) or presence of any disorder within a combination of disorders (e.g. any phobia disorder).

In addition, clinical judgments regarding a priori factor assignment of each variable in the hypothesized
CFA model were made based on the relative importance of internalizing and externalizing symptoms for
various disorders. The internalizing factor consisted
largely of anxiety disorders, and the externalizing factor consisted largely of drug and alcohol use disorders.
Due to sparseness of somatoform disorders, we decided a priori to include somatoform disorders and eating disorders in one variable, which we hypothesized
to be explained by the internalizing factor (see Table 1).
The factor scores and subject clusters for the 1156 BPI
individuals were validated by testing their associations
with clinical course variables known to be related to
prognosis, severity and impairment (see Table 2 footnote for deﬁnitions). In each model, a clinical course
variable was the dependent variable. The independent
variables were the factors or clusters, adjusted for gender of BPI subject. Linear and logistic regression models
were estimated using the SAS generalized linear modeling (GENMOD) procedure with the ‘generalized
estimating equations’ (GEE) (Liang & Zeger, 1986) estimation method to account for within-family correlations. For continuous outcomes, rank scores (robust to
skewness) of the outcome, the normal error distribution,
and the linear link were speciﬁed. For binary outcomes,
the binomial error distribution and the exchangeable
log odds ratio regression structure were speciﬁed.

For the familial analysis, only ﬁrst-degree relatives
were included. Four clusters of probands were compared on binary disorders of relatives using GEE
with GENMOD, as described above, and on an unordered eight-category dependent variable (eight clusters
in relatives) using the SAS SURVEYLOGISTIC procedure, to account for within-family correlations. The
familial models were adjusted for gender and age of
relatives.
All tests were two-sided with α of 0.05. Post-hoc pairwise comparisons were tested only if the omnibus test
was signiﬁcant (i.e. the protected version of Fisher’s
least signiﬁcant difference).
Ethical standards
All procedures contributing to this work comply with
the ethical standards of the relevant national and institutional committees on human experimentation and with
the Helsinki Declaration of 1975, as revised in 2008.
Results
Participant characteristics
The 504 probands (from 504 multiplex families) with
BPI disorder (96%) or schizo-affective BP type (4%)
were adults; age at interview ranged from 18 to 88
years (except one was aged 17 years). The 1157

Table 2. Factors and clinical course of illness variables among BPI participants (BPI probands and BPI relatives)a
Factor 2 (externalizing factor)

Factor score

Factor score

0

1

2, 3, or 4

711
(1)

288
(2)

157
(3)

Omnibus p

Post-hoc pairwise tests

0

1

2 or 3

609
(1)

274
(2)

273
(3)

Omnibus p

Post-hoc pairwise tests

19
0.43
1.00
0.17
70

17
0.57
0.80
0.17
65

15
0.87
1.00
0.19
61

***
***
N.S.
N.S.
***

ALL
ALL
N .A .
N .A .
(1) > (2)(3)

19
0.48
1.00
0.16
70

18
0.48
1.00
0.17
70

16
0.58
1.00
0.21
61

***
N . S.
N . S.
N . S.
***

ALL
N.A.
N.A.
N.A.
(1)(2) > (3)

55
17
47
11
9
39
23

69
20
52
12
10
53
30

81
25
62
14
13
71
36

***
*
N.S.
N.S.
N.S.
***
**

ALL
(1)(2) < (3)
(1) < (3)
N .A .
N .A .
ALL
(1) < (2)(3)

68
17
45
11
8
42
23

62
17
57
13
10
46
27

50
25
55
11
13
59
34

***
*
**
N . S.
N . S.
***
**

(1)(2) > (3)
(1)(2) < (3)
(1) < (2)(3)
N.A.
N.A.
(1)(2) < (3)
(1) < (3)
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BPI, Bipolar I; ALL, all three pairwise differences were signiﬁcant; N.S., not signiﬁcant; N.A., post-hoc pairwise tests not applicable because omnibus test not signiﬁcant; GAS, global
assessment score; DIGS, Diagnostic Interview for Genetic Studies.
a
The sum score, computed separately for internalizing and externalizing variables, was speciﬁed in models as a categorical variable with three levels (no disorders, one variable,
two or more variables) because validation results were similar for sum scores and coefﬁcient-weighted factor scores. Each row represents a different regression model (linear and
logistic, respectively, for continuous and binary clinical course dependent variables), estimated using a generalized linear model (SAS GENMOD) with generalized estimating equations to account for within-family correlations.
b
Episode frequency = number of clean (i.e. episodes not likely to be caused by a speciﬁc organic factor, such as drug abuse, medication, or disease) affective episodes per years of illness.
c
Mania/depression episode ratio = number of clean manic episodes over the number of clean depressive episodes.
d
Psychiatric hospitalizations per years ill = number of hospitalizations divided by years of illness.
e
Between-episode GAS = GAS for the past month if not hospitalized, otherwise GAS equals missing value.
f
Disabled = occupationally disabled, from the present job question in DIGS 3.0.
g
Presence of psychotic symptoms = at least one of ﬁve psychotic screening items in the DIGS 3.0 psychosis section deﬁnitely present and lasted persistently throughout the day for
1 day or intermittently for a period of 3 days.
h
Mood-incongruent psychotic symptoms were present during either a mania or depression episode assessed in DIGS 3.0.
i
Rapid cycling = four or more discrete episodes of mania or depression within 12 months demarcated by 8 weeks or more of remission.
j
Rapid switching = positive on the mania screening item in the DIGS mania section: ‘ever switched quickly from high to normal or high to depressed without normal mood between’.
k
Mixed states = at least three symptoms of the opposite polarity lasting 1 week or more, plus positive on stem question ‘During this episode did you have a week or more during
which your mood frequently changed between irritability or elation and sadness or depression?’ in either the mania or depression sections of DIGS 3.0.
* p < 0.05, ** p < 0.01, *** p < 0.001.

Conﬁrmatory test of two factors and four subtypes of bipolar disorder

Number of BPI participants
Factor score group number
Continuous clinical variables
Median age of onset, years
Median episode frequency per years illb
Median mania/depression episode ratioc
Median psychiatric hospitalizations per years illd
Median between-episode GASe
Binary clinical variables (1 = yes, 0 = no), %
Female
Disabledf
Psychotic symptomsg
Mood-incongruent psychotic symptomsh
Rapid cyclingi
Rapid switchingj
Mixed statesk

Factor 1 (internalizing factor)
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ﬁrst-degree relatives of the 504 probands included
mostly adults (range 18–93 years) with only eight
(1%) adolescents (range 13–17 years). The high percentage of ﬁrst-degree relatives with BPI or schizo-affective
BP type (48.6%) was a function of multiplex family
ascertainment.
The main analyses (i.e. testing CFA and CLCA hypotheses and validating against clinical course variables) were based on 1156 persons with BPI disorder
or schizo-affective BP type (504 adult probands; 594
ﬁrst-degree relatives; and 58 more distant relatives)
(see online Supplementary Table S1). At time of interview, 44% of those with BPI were married. Their median age of onset was 18.0 years. The majority was
female and Caucasian. Prevalence of co-morbid lifetime disorders is shown in online Supplementary
Table S1.

the clinical course variables (Table 2). A complete
dose–response relationship was observed for age of
onset, episode frequency, gender and rapid switching,
particularly for the internalizing score (all pairwise
differences were signiﬁcant). In addition, for interepisode global assessment score (GAS), disability, history of psychotic symptoms and mixed states, one or
two of the pairwise differences were signiﬁcant and
the means and percentages of clinical course variables
generally showed dose–response trends (Table 2).
There were no signiﬁcant interactions between the
internalizing and externalizing sum scores, except for
mixed states (p = 0.029). Thus, the relationship with
clinical course for one factor generally did not depend
on whether participants scored low or high on the
other factor.
Test of the CLCA model

Test of the CFA model
All variables demonstrated large standardized factor
loadings (0.50 or greater) on their hypothesized factor
(Table 1). The CFA model demonstrated excellent ﬁt to
the data (CFI = 1.000, RMSEA = 0.000, WRMR = 0.556).
The null hypothesis of good ﬁt was not rejected by the
χ2 goodness of ﬁt test [χ2 = 9.29, degrees of freedom
(df) = 11, p = 0.60]. The two factors were signiﬁcantly correlated as hypothesized (r = 0.34, p < 0.001). A one-factor
model showed poor ﬁt (CFI = 0.76, RMSEA = 0.094,
WRMR = 1.65, χ2 = 156.63, df = 14, p < 0.001). No statistically signiﬁcant improvement upon the two-factor
model could be found by adding or deleting paths.
The eigenvalues further supported a two-factor solution
(see online Supplementary Text, Section D).
Associations between factors and clinical course
variables
Comparison of factor-scoring methods
Validation with clinical course variables was initially
performed for both the CFA-coefﬁcient-weighted factor scores and the commonly used sum scale score
(one point for each variable). Results were similar for
the two methods (see online Supplementary
Table S2). Therefore, validation results are reported
next using the sum score because it can be easily computed by hand during clinical encounters and it lent itself to disseminating dose–response relationships
according to three clinically sensible categories: no disorders; one variable; and two or more variables (frequencies with three or four variables were sparse).
Associations between factors and clinical course variables
A signiﬁcant association with internalizing and externalizing sum scores was observed for a majority of

The ﬁt of the hypothesized CLCA model was compared with a wide range of exploratory LCA models
and post-hoc modiﬁed CLCA models to strongly test
its resilience (Table 3). Both alternatives of the hypothesized CLCA model (models no. 1 and no. 2) ﬁt better
(lower BIC and aBIC) than all exploratory (one-class
to six-class) models (models no. 3 to no. 8). The
ﬁve-class and six-class exploratory models were not
meaningful due to one or more classes having only
1% membership. The hypothesized CLCA model
with full equality constraints (model no. 1) ﬁt the
best; its ﬁt was slightly better than the competing
CLCA model with full inequality constraints (model
no. 2) and also better than all post-hoc modiﬁed
CLCA models (models no. 9 to no. 16).
Further non-essential description of CLCA results in
Table 3 is provided in Section D of online
Supplementary Text. In summary, none of the post-hoc
modiﬁed four-class CLCA models or any of the oneclass to six-class exploratory LCA models ﬁt better
than the CLCA model that was hypothesized to have
deterministic constraints and full equality constraints
(model no. 1).
Associations between CLCA-derived BPI subtypes and
clinical course variables
BPI subtypes, based on most likely class membership
from the best CLCA model (model no. 1), were compared on clinical course variables. Signiﬁcant associations were found for seven of the 12 clinical course
variables and in the anticipated directions (Table 4).
For example, the median age of onset of major affective
disorder was highest for those with no co-morbid disorders (19.0 years) and lowest for those with both
internalizing and externalizing variables (16.0 years).
All pairwise differences were signiﬁcant for age of

Table 3. CLCA of seven lifetime co-morbid diagnostic variables (n = 1156 for all models)
Most likely class membership size, n (%)a
Model
no.

Constraints

Log
likelihood

No. of free
parameters

BIC

aBIC

LMR p

4
4

−3288
−3284

10
17

6647
6687

6616
6633

<0.0001
N.A.

422 (37)
422 (37)

1
2
3
4
5
6

−3520
−3343
−3283
−3266
−3259
−3254

7
15
23
31
39
47

7089
6791
6727
6751
6793
6840

7067
6744
6654
6652
6669
6691

N.A.
<0.0001
<0.0001
0.19
0.13
0.63

1156 (100)
389 (34)
101 (9)
616 (53)
7 (1)
604 (52)

4
4
4
4
4
4
4
4

−3285
−3288
−3285
−3284
−3285
−3284
−3288
−3273

13
14
12
17
13
17
11
24

6661
6674
6655
6687
6661
6687
6655
6715

6619
6629
6617
6633
6619
6633
6620
6639

<0.0001
<0.0001
<0.0001
N.A.
N.A.
<0.0001
<0.0001
0.07

1

422
422
422
422
422
422
422
422

(37)
(37)
(37)
(37)
(37)
(37)
(37)
(36)

2

3

4

187 (16)
187 (16)

289 (25)
289 (25)

258 (22)
258 (22)

767
725
144
124
7

(66)
(63)
(12)
(11)
(1)

330 (28)
101 (9)
376 (32)
150 (13)

295 (26)
102 (9)
277 (24)

187
187
187
187
187
187
187
285

(16)
(16)
(16)
(16)
(16)
(16)
(16)
(25)

289 (25)
289 (25)
289 (25)
289 (25)
277 (24)
289 (25)
289 (25)
126 (11)

258
258
258
258
270
258
258
323

(22)
(22)
(22)
(22)
(23)
(22)
(22)
(28)
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CLCA, Conﬁrmatory latent class analysis; BIC, Bayesian information criterion; aBIC, sample size-adjusted BIC; LMR p, Lo–Mendell–Rubin test p value; Zero-c, zero-class speciﬁed
by using a deterministic constraint to ﬁx the probabilities of endorsing each of the seven variables to be zero; Int, internalizing; Ext, externalizing; Int-only-c, internalizing-only class
speciﬁed using a deterministic constraint to ﬁx the probabilities of endorsing externalizing disorders to be zero; Ext-only-c, externalizing-only class speciﬁed using a deterministic constraint to ﬁx the probabilities of endorsing internalizing disorders to be zero; Both-c, both-class speciﬁed by allowing all probabilities for endorsing the four internalizing and the
three externalizing variables to be freely estimated; Full Eq, full equality constraints in which endorsement probabilities of externalizing variables were constrained to be equal for the
externalizing-only class and the both-class, and endorsement probabilities of internalizing variables were constrained to be equal for the internalizing-only class and the both-class;
Full InEq, full inequality constraints in which endorsement probabilities of externalizing variables were constrained to be less for the externalizing-only class than the both-class, and
endorsement probabilities of internalizing variables were constrained to be less for the internalizing-only class than the both-class; N.A., LMR test not available for models with (nonlinear) inequality constraints and not applicable for an exploratory model with one class; Eq(Int only), Eq(Ext only), Eq(Alc only), instead of full equality constraints on all variables,
the equality constraint was placed on only the four internalizing variables, or only the three externalizing variables, or only the one alcohol variable, respectively; InEq(Ext only), instead of full inequality constraints on all variables, the inequality constraint was placed on only the three externalizing variables; Int-only + Alc-c, instead of an internalizing-only
class, an internalizing-only-plus-alcohol class was speciﬁed using a deterministic constraint to ﬁx the probabilities of endorsing externalizing disorders to be zero except for one externalizing variable, alcohol abuse or dependence disorders, for which the probability of endorsement was allowed to be freely estimated along with the internalizing disorders.
a
The most likely class membership size was 547 (47%) for class 5 for model no. 7, and were 17 (1%) and 101 (9%) for classes 5 and 6, respectively, for model no. 8.

Conﬁrmatory test of two factors and four subtypes of bipolar disorder

Two competing CLCA models
1
Zero-c, Int-only-c, Ext-only-c, Both-c, Full Eq
2
Zero-c, Int-only-c, Ext-only-c, Both-c, Full InEq
Exploratory LCA models
3
None
4
None
5
None
6
None
7
None
8
None
Post-hoc modiﬁcations to CLCA models
9
Model no. 1, except Eq(Int only)
10
Model no. 1, except Eq(Ext only)
11
Model no. 1, except Eq(Alc only)
12
Model no. 2, except InEq(Ext only)
13
Model no. 1 or no. 2, except Eq(Int only) and InEq(Ext only)
14
Model no. 1 or no. 2, except no Eq and no InEq constraints
15
Model no. 1, except Int-only + Alc-c
16
Zero-c, no other constraints

No. of
classes

Clusters based on DSM-IV diagnosed co-morbid disorders

Number of BPI probands and
BPI relatives
Cluster group number
Continuous clinical variables
Median age of onset of major
affective disorder, years
Median episode frequency
per years ill
Median manic/depressive
episode ratio
Median psychiatric
hospitalizations
per years ill
Median between-episode
GAS
Binary clinical variables
(1 = yes, 0 = no), %
Female
Disabled
Psychotic symptoms
Mood-incongruent
Psychotic symptoms
Rapid cycling
Rapid switching
Mixed states

None of the
co-morbid disorders

Internalizing
disorder(s) only

Externalizing
disorder(s) only

Internalizing and
externalizing disorder(s)

422

187

289

258

(1)

(2)

(3)

(4)

19.0

17.0

18.0

16.0

Omnibus p

Post-hoc pairwise comparisons
between clusters

***

(1) > (2)(3)(4); (2) > (4); (3) > (4)

0.43

0.62

0.44

0.69

***

(1) < (2)(4); (2) > (3); (3) < (4)

1.00

0.75

1.00

1.00

N.S.

N.A.

0.17

0.16

0.19

0.19

N.S.

N.A.

***

(1) > (2)(4); (3) > (4)

70

65

70

64

61
16
41
11

83
18
54
13

47
18
56
12

66
24
56
12

6
34
19

10
59
33

11
46
30

12
60
32

***

(1) < (2); (1) > (3); (2) > (3)(4); (3) < (4)

N.S.

N.A.

**

(1) < (3)(4)

N.S.

N.A.

N.S.
***
***

N.A.
(1) < (2)(3)(4); (3) < (4)
(1) < (2)(3)(4)

BPI, Bipolar I; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, 4th edition; N.S., not signiﬁcant; N.A., pairwise tests not applicable because omnibus test was not signiﬁcant; GAS, global assessment score.
a
Each row represents a different regression model (linear and logistic, respectively, for continuous and binary clinical course dependent variables), estimated using a generalized linear model (SAS GENMOD) with generalized estimating equations to account for within-family correlations.
** p < 0.01, *** p < 0.001.
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Table 4. Clusters and course of illness variables among BPI participants (BPI probands and BPI relatives)a

Conﬁrmatory test of two factors and four subtypes of bipolar disorder
onset except for the difference between ‘internalizingonly’ and ‘externalizing-only’ classes. The presence of
internalizing disorders, either alone or in combination
with externalizing disorders, was associated with
greater episode frequency and lower GAS. Persons in
class 1 (pure BPI without co-morbidity) were less likely
to have a history of psychotic symptoms than persons
with externalizing disorders only (class 3) or persons
with both internalizing and externalizing disorders
(class 4). All three groups of BPI individuals with
co-morbidity had signiﬁcantly greater history of
rapid switching and mixed states than the cluster
without co-morbidity (class 1). Rapid switching was
particularly elevated for the two clusters with internalizing disorders.
Familial analysis
There were eight possible co-morbidity clusters of
ﬁrst-degree relatives deﬁned by crossing the presence
of BPI or other affective disorders with the four
co-morbidity classes that were deﬁned for BPI probands from the best CLCA model. The four clusters
of probands were signiﬁcantly associated with the
eight clusters of relatives, indicating signiﬁcant familial
aggregation of the hypothesized clusters after adjusting for gender and age of relatives (Table 5; 4 × 8 omnibus test, p < 0.001). In particular, rates for three of the
relative clusters differed between the four proband
clusters (4 × 2 omnibus tests, p < 0.001, 0.045 and
0.001). Speciﬁcally, relatives were more likely to have
pure affective disorder without other internalizing or
externalizing disorders (36%) if their proband also
had pure BPI (cluster 1). Relatives were also more
likely to have affective disorder with both internalizing
and externalizing disorders (17%) if the proband also
had BPI with both internalizing and externalizing disorders (cluster 4). Finally, relatives were more likely to
have affective disorders with other internalizing disorders and no externalizing disorders (18%) if the BPI
proband also had internalizing disorders only (cluster
2), compared with relatives of pure BPI probands (cluster 1) or BPI probands with externalizing disorders
only (cluster 3).
The remaining familial analyses in Table 5 pertain to
individual disorders. To summarize, several disorders
and groups of disorders among the relatives differed
signiﬁcantly between the four proband clusters and
in the anticipated directions (Table 5).
Discussion
Synthesis of ﬁndings
The proposed two-factor CFA model showed an
excellent ﬁt to the data, suggesting inter-correlated
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internalizing and externalizing co-morbid factors in
the context of BPI. Additional validity of the two-factor
co-morbidity model was supported by signiﬁcant associations in anticipated directions between higher internalizing and externalizing factor scores and a majority
of the clinical course variables that typically indicate
worse prognosis, severity and impairment.
For the second set of analyses, the a priori hypothesized CLCA model with full equality constraints
(model no. 1) ﬁt the data better than a range of 15
other models, including the competing hypothesized
CLCA model with full inequality constraints, eight
post-hoc modiﬁcations to both versions of the CLCA
model, and six exploratory models. This best-ﬁtting
four-class model had a ‘zero’, ‘internalizing-only’,
‘externalizing-only’ and ‘both’ class. The four subject
clusters or BPI subtypes, based on the best-ﬁtting
hypothesized CLCA model, demonstrated signiﬁcant
differences on a majority of the clinical course variables, supporting the meaningful interpretation of
these subtypes. The ﬁndings from familial analysis
offered further support for these four clusters of BPI
individuals.
A remarkable aspect about the results is the differences between ‘pure’ BPI and BPI with any comorbidity. ‘Pure’ BP runs in families, it has a later
age of onset of major affective disorder in our data,
generally lower episode frequency and less interepisode impairment, fewer psychotic symptoms, and
less evidence of rapid switching and mixed states.
That is, many of the ‘complications’ of BP disorder
that are typically regarded as evidence of more severe
disorder are differentially clustered in subjects with
co-morbid disorders.
More work is needed to evaluate whether the presence of co-morbid anxiety disorders in children diagnosed with BP may be a marker of very early-onset
BP (Wozniak et al. 2002). Our ﬁndings suggest that
the presence of either anxiety disorders (and/or other
internalizing disorders) or externalizing disorders
(such as substance use) is a marker of earlier onset of
major affective disorder in adults diagnosed with BP.
These features may be clearly noted in the two-factor
validation ﬁndings as well. Here the ‘pure’ subjects
with zero trait presence on the factor score are seen
to have later age of onset and fewer psychotic symptoms than those with any externalizing disorder, and
lower episode frequency and evidence of mixed states
than those with any internalizing disorder.
The other remarkable aspect of this analysis is the
‘dose–response’ demonstration that the presence of a
greater number of co-morbid disorders, either internalizing or externalizing, is associated with a distinct
worsening of course of illness. This is particularly
true with regard to the incidence of disability, poor

Post-hoc pairwise comparisons
between clusters

Proband clusters based on DSM-IV co-morbid diagnoses

Cluster group number
Number in each BPI proband cluster
Number of their FDRs
Clusters in FDRs
No affective disorder + no Int or Ext disorder
No affective disorder + Int disorder(s) only
No affective disorder + Ext disorder(s) only
No affective disorder + Int and Ext disorder(s)
Affective disorder + no Int or Ext disorder
Affective disorder + Int disorder(s) only
Affective disorder + Ext disorder(s) only
Affective disorder + Int and Ext disorder(s)
Affective disorders in FDRs
BPIb
MDDR
SEMD
Any bipolar disorder NOSd
Any depressive disorder NOSe
Any affective disorder
Internalizing disorders in FDRs
Anxiety disorders
Panic disorder without agoraphobia
Panic disorder with agoraphobia
Agoraphobia without panic attacks
Anxiety disorder NOS
GAD
PTSD
Any anxiety disorder except phobia and
OCD (v1)f
Social phobia
Speciﬁc phobia
Any phobia (v2)f
OCD (v3)f

None of the
co-morbid disorder(s)

Int disorder(s)
only

Ext disorder(s)
only

Int and Ext
disorder(s)

(1)
177
406

(2)
79
171

(3)
121
301

(4)
127
279

18
2
4
2
27
18
17
13

23
2
11
3
20
9
20
14

15
2
8
3
22
14
19
17

<0.001
0.391
0.768
0.110
N.A.
<0.001
0.045
0.169
0.001

N.S.

23
3
7
1
36
9
16
6

N.A.
N.A.

49
9
5
2
4
67

53
11
4
5
4
74

46
7
5
1
3
62

48
14
6
3
6
73

0.652
0.114
0.753
N.A.
0.436
0.204

5
3
2
1
0
0.3
11

14
8
1
3
0
1
25

13
5
1
1
0.3
1
19

13
11
2
3
0
1
27

<0.001
0.002
0.770
0.340
N.A.
N.A.
<0.001

3
4
7
2

8
12
16
10

4
7
10
2

7
10
16
3

0.143
0.007
0.003
0.036

Omnibus pc

(1)
(2)

(1)
(3)

(1)
(4)

(2)
(3)

(2)
(4)

(3)
(4)

*

*

N.S.

N.S.

N.S.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

*
*

*

*

N.S.

N.S.

N.S.

N.S.

N.S.

*

N.S.

N.S.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.S.

*

*

N.S.

N.S.

N.S.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.S.

*

*

N.S.

N.S.

*
*

N.S.

N.S.

N.S.

N.S.

*

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

*

*

*

N.S.

N.S.

N.S.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

*
*
*

N.S.

N.S.

N.S.

N.S.

N.S.

*
*

N.S.

N.S.

*

N.S.

N.S.

*

*

N.S.
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Table 5. Familial aggregation: clusters and disorders of FDRs by BPI proband clustersa

16
0.3
4
4
18
4

34
0
6
6
35
17

26
0.3
3
3
27
7

34
2
4
6
36
13

<0.001
N.A.
N.A.
N.A.
<0.001
<0.001

*

*

*

N.S.

N.S.

N.S.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

*
*

*

*
*

N.S.

N.S.

N.S.

*

N.S.

N.S.

17
8
25
10
9
15
29
1
0.3
1
1
0.5
4
30
12
33

20
10
29
15
5
18
34
2
0
2
2
0
5
36
15
26

27
14
40
20
12
27
47
4
0.3
1
4
0
8
47
21
35

28
11
37
19
12
25
45
3
0.4
3
1
1
7
47
20
42

0.002
0.077
<0.001
0.002
0.038
<0.001
<0.001
0.025
N.A.
N.A.
N.A.
N.A.
0.187
<0.001
0.001
0.034

N.S.

*

*

N.S.

N.S.

N.S.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.S.

*
*

*

N.S.

N.S.

N.S.

*
*

N.S.

N.S.

N.S.

N.S.

N.S.

N.S.

N.S.

*
*
*

*
*
*

*
*
*

N.S.

N.S.

*
*
*
N.S.

N.S.

N.S.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.S.

*
*

N.S.

N.S.

N.S.

N.S.

N.S.

*
*
*

*

N.S.

*
*

N.S.

*

N.S.

N.S.

N.S.

N.S.
N.S.

2191

Data are given as column percentages unless otherwise indicated.
FDR, First-degree relative; MDD, major depressive disorder; BPI, any BPI including BPI with mania and MDD, BPI manic never MDD, BPI mixed never manic, or schizo-affective
bipolar; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, 4th edition; Int, internalizing; Ext, externalizing; N.S., not signiﬁcant; N.A., not applicable; MDDR, MDD recurrent; SEMD, single-episode MDD; NOS, not otherwise speciﬁed; GAD, generalized anxiety disorder; PTSD, post-traumatic stress disorder; OCD, obsessive compulsive disorder;
ADHD, attention-deﬁcit/hyperactivity disorder; GEE, generalized estimating equations.
a
Each row represents a different logistic regression model, accounting for within-family correlations by using GEE (SAS GENMOD with GEE) for binary dependent variables and
maximum likelihood estimation with variance adjustment based on the cluster structure (SAS SURVEYLOGISTIC) for the unordered eight-category dependent variable (eight clusters
in relatives).
b
The number of FDRs with BPI was mostly predetermined because BPI disorder in at least one FDR of each proband was an ascertainment criterion.
c
An ‘N.A.’ in the column for omnibus p indicates that the models could not converge due to low prevalence of these disorders.
d
Any bipolar disorder NOS, diagnosed with bipolar disorder NOS or bipolar II SEMD or cyclothymia or hypomania.
e
Any depressive disorder NOS, diagnosed with depressive disorder NOS or dysthymia or adjustment disorder.
f
The seven variables (v1 to v7) were deﬁned a priori before analyses. In the ﬁrst column, the rows with (v1), (v2), (v3), (v4), (v5), (v6) and (v7) represent the seven variables analysed in the conﬁrmatory factor analysis and conﬁrmatory latent class analysis models.
* p < 0.05.

Conﬁrmatory test of two factors and four subtypes of bipolar disorder

Any anxiety disorders
Somatization disorder
Any eating disorder
Any eating or somatoform disorder (v4)f
Any Int disorder
Two, three or four Int variables
Ext disorders in FDRs
Alcohol dependence
Alcohol abuse
Alcohol dependence or abuse (v5)f
Drug dependence
Drug abuse
Drug dependence or abuse (v6)f
Any substance use disorder
Antisocial personality disorder
Borderline personality disorder
Pathological gambling
Conduct disorder
ADHD
Cluster B, impulse, conduct, ADHD (v7)f
Any Ext disorder
Two or three Ext variables
Habitual smoking
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inter-episode functioning, rapid switching and mixed
states. The same pattern is seen in Table 3. Those subjects in the group with both externalizing and internalizing disorders are more symptomatic in multiple
areas than subjects in the other clusters.
Are subjects with only internalizing co-morbid disorders different from subjects with only externalizing
co-morbid disorders? First, they are more likely to be
female (Table 3). Thus, it is important to emphasize
that the comparisons of other clinical course variables
in Tables 2 and 3, many of which were signiﬁcant,
were adjusted for gender.
Additionally, at least one externalizing disorder
seems to have less of an impact on course of illness
compared with having at least one internalizing disorder (consider episode frequency, inter-episode
GAS, rapid switching and mixed states, all of which
were different from ‘pure’ BP in subjects with one
internalizing disorder but not in those with one externalizing disorder; Table 2). A single externalizing disorder, on the other hand, is associated with an
increased chance of psychotic symptoms, whereas having one or more internalizing disorders is not. The familial analysis is notable in that alcohol and drug use
disorders both aggregate in the relatives of subjects
with externalizing disorders but not in the relatives
of subjects without such disorders.
The results here, using different statistical methods,
are largely consistent with our previous results found
in a high-risk study using a different dataset entirely;
speciﬁcally, two groups of childhood disorders (anxiety and externalizing) predicted subsequent major affective illness in adolescents of families with
probands with adult BP disorder (Nurnberger et al.
2011). In the present study, the two same factors
were shown through conﬁrmatory tests of hypotheses
to distinguish subtypes of adults with BPI.
Numerous studies have used exploratory factor
analysis and CFA to factor analyse symptoms of BP, including the symptoms or signs of mania (Bräunig et al.
1996; Serretti et al. 1999; Perugi et al. 2001; Faraone et al.
2004; Krüger et al. 2010), other mood or psychotic
symptoms (Bauer et al. 1991; Dilsaver et al. 1999;
Akiskal et al. 2001; Swann et al. 2001, 2008;
Daneluzzo et al. 2002; Sato et al. 2002; González-Pinto
et al. 2003; Berk et al. 2007; Henry et al. 2007; Adida
et al. 2008; Adler et al. 2008; Erkiran et al. 2008;
Harvey et al. 2008; Lindenmayer et al. 2008;
Cavanagh et al. 2009; Gupta et al. 2009; Thompson
et al. 2010; Mitchell et al. 2013), cognitive and energy
features (Cassano et al. 2009), temperament (Evans
et al. 2005), attention-deﬁcit/hyperactivity disorder
(ADHD) features (Joo et al. 2010) or childhood trauma
signs (Garno et al. 2005). Resulting factors were shown
to be modestly beneﬁcial for genetic mapping in

studies of BP, with respect to mood-disturbance factors
(Faraone et al. 2004; Savitz et al. 2008) and an ADHD
‘inattention’ factor (Joo et al. 2010). We anticipate that
subtyping using clinical co-morbidity will continue to
shed light on the clinical and genetic characteristics
of BPI.
To date, there have been only four published studies
using cluster analysis or LCA among BPI patients to
determine subtypes, all using the exploratory approach
(Dilsaver et al. 1999; Cassidy et al. 2001; Swann et al.
2001; Sato et al. 2002). These studies cluster-analysed
either the factor scores derived from the symptoms
and behavioral ratings related to BPI or the symptoms
and ratings themselves (Cassidy et al. 2001). Their
results revealed more similarities than differences
(Cassidy & Carroll, 2003; Sato et al. 2003). For example,
all four studies found a pure (i.e. predominantly euphoric) subtype and a mixed (i.e. depressive or
anxious–depressive) subtype. Using a conﬁrmatory
approach applied to lifetime disorders, we found supporting evidence for a four-class lifetime co-morbidity
model in BPI individuals. A future CLCA on symptoms common to multiple co-morbid disorders
among BPI patients would add beneﬁcial knowledge
to the present CLCA ﬁndings of distinct lifetime
co-morbid disorders.
In previous exploratory BPI cluster analyses, differences were found between clusters on acute pharmacological treatment response (Swann et al. 2002); masked
independent clinical classiﬁcation of mixed states but
not on gender (Dilsaver et al. 1999); and gender, suicidality at admission, and social adjustment and residual
symptoms at discharge, but not on age of onset (Sato
et al. 2002). The present study, based on lifetime
diagnoses instead of symptoms, established additional
differences between classes that demonstrated conﬁrmatory support. It should be noted that our sample
size was larger, with more power to detect group differences on clinical course variables, than the previous
studies which consisted of 105 (Dilsaver et al. 1999), 162
(Swann et al. 2001), 327 (Cassidy et al. 2001) and 576
(Sato et al. 2002) BPI in-patients.

Limitations
It is possible that other variables not measured in the
present study, such as traumatic stress, could improve
the ﬁt of the CFA and CLCA models. Medications
could be a confounding or determining factor for clustering; however, the present dataset was not capable of
addressing this issue. Test–retest reliability was not
assessed for the co-morbid disorders. This multiplex
sample is highly familial and the results may or may
not be applicable to sporadic BPI disorders.

Conﬁrmatory test of two factors and four subtypes of bipolar disorder
Conclusions
There appears to be strong evidence for the two-factor
and four-cluster lifetime co-morbidity hypotheses.
These hypotheses may be useful for understanding
etiology and risk. The factors and clusters could be
useful for parsimoniously reducing the number of variables in analyses of family, high-risk and case–control
studies of persons living with BPI. These constructs
may be useful for subtyping BP disorders and for prognosis by predicting course and severity of illness.
Subtypes may also be useful for reﬁning the phenotype
in genetic studies. Subtypes may also have value for
personalized medicine (Hamburg & Collins, 2010), assuming clinical subtypes could be linked to molecularly distinct subtypes, which may lead to new
therapeutic possibilities, either through the development of targeted drugs or the salvaging of abandoned
or failed drugs by identifying subgroups of patients
likely to beneﬁt from them.
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